Mirum Pharmaceuticals, Inc. MIRM Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s intangible purchases?
- Mirum Pharmaceuticals, Inc. (MIRM) reported intangible purchases of $10M in Q1 2026.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s intangible purchases?
- Over 2 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s intangible purchases has grown at a -100.0% compound annual growth rate (CAGR), from $19M to $0.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.